aluates Reports

$ 0.0

Automative

Global Non-alcoholic Steatohepatitis Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-38Z12000

Global Non alcoholic Steatohepatitis Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Non-alcoholic Steatohepatitis Market Research Report 2025

Code: QYRE-Auto-38Z12000

Report

August 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

GSK

Novo Nordisk

Roche

Galectin Therapeutics

Galmed Pharmaceuticals

Gilead

Takeda

Pfizer Inc

AbbVie

Intercept pharma

Non-alcoholic Steatohepatitis

Non-alcoholic Steatohepatitis Market Size

The global market for Non-alcoholic Steatohepatitis was valued at US$ 3664 million in the year 2024 and is projected to reach a revised size of US$ 13350 million by 2031, growing at a CAGR of 20.6% during the forecast period.

Non-alcoholic Steatohepatitis Market

Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.

NASH is a progressive liver disease characterized by fat accumulation in the liver, inflammation, and liver cell damage, typically occurring in individuals who do not consume excessive alcohol. Several factors are driving the growth of the NASH market. Firstly, the rising prevalence of obesity and metabolic disorders, such as diabetes and dyslipidemia, is contributing to the increasing incidence of NASH. Unhealthy lifestyles, sedentary habits, and poor dietary choices are leading to a higher risk of developing NASH, creating a substantial patient population in need of diagnosis and treatment. Secondly, the improved understanding and awareness of NASH among healthcare professionals and the general population have resulted in increased diagnosis rates. As the medical community recognizes the long-term complications and progression of NASH, there is a greater emphasis on identifying patients with NASH and implementing appropriate management strategies.

This report aims to provide a comprehensive presentation of the global market for Non-alcoholic Steatohepatitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-alcoholic Steatohepatitis.

The Non-alcoholic Steatohepatitis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-alcoholic Steatohepatitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-alcoholic Steatohepatitis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-alcoholic Steatohepatitis Market Report

Report Metric	Details
Report Name	Non-alcoholic Steatohepatitis Market
Accounted market size in year	US$ 3664 million
Forecasted market size in 2031	US$ 13350 million
CAGR	20.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Solid Liquid
Segment by Application	Oral Parenteral
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Pfizer, GSK, Novo Nordisk, Roche, AbbVie, Galectin Therapeutics, Galmed Pharmaceuticals, Gilead, Intercept pharma, Non-alcoholic Steatohepatitis, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-alcoholic Steatohepatitis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-alcoholic Steatohepatitis Market growing?

Ans: The Non-alcoholic Steatohepatitis Market witnessing a CAGR of 20.6% during the forecast period 2025-2031.

What is the Non-alcoholic Steatohepatitis Market size in 2031?

Ans: The Non-alcoholic Steatohepatitis Market size in 2031 will be US$ 13350 million.

Who are the main players in the Non-alcoholic Steatohepatitis Market report?

Ans: The main players in the Non-alcoholic Steatohepatitis Market are AstraZeneca, Pfizer, GSK, Novo Nordisk, Roche, AbbVie, Galectin Therapeutics, Galmed Pharmaceuticals, Gilead, Intercept pharma, Non-alcoholic Steatohepatitis, Takeda

What are the Application segmentation covered in the Non-alcoholic Steatohepatitis Market report?

Ans: The Applications covered in the Non-alcoholic Steatohepatitis Market report are Oral, Parenteral

What are the Type segmentation covered in the Non-alcoholic Steatohepatitis Market report?

Ans: The Types covered in the Non-alcoholic Steatohepatitis Market report are Solid, Liquid

Recommended Reports

Liver Disease Treatment

Metabolic Disorder Markets

Liver Cancer & Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-alcoholic Steatohepatitis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Solid

1.2.3 Liquid

1.3 Market by Application

1.3.1 Global Non-alcoholic Steatohepatitis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oral

1.3.3 Parenteral

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-alcoholic Steatohepatitis Market Perspective (2020-2031)

2.2 Global Non-alcoholic Steatohepatitis Growth Trends by Region

2.2.1 Global Non-alcoholic Steatohepatitis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-alcoholic Steatohepatitis Historic Market Size by Region (2020-2025)

2.2.3 Non-alcoholic Steatohepatitis Forecasted Market Size by Region (2026-2031)

2.3 Non-alcoholic Steatohepatitis Market Dynamics

2.3.1 Non-alcoholic Steatohepatitis Industry Trends

2.3.2 Non-alcoholic Steatohepatitis Market Drivers

2.3.3 Non-alcoholic Steatohepatitis Market Challenges

2.3.4 Non-alcoholic Steatohepatitis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-alcoholic Steatohepatitis Players by Revenue

3.1.1 Global Top Non-alcoholic Steatohepatitis Players by Revenue (2020-2025)

3.1.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Players (2020-2025)

3.2 Global Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-alcoholic Steatohepatitis Revenue

3.4 Global Non-alcoholic Steatohepatitis Market Concentration Ratio

3.4.1 Global Non-alcoholic Steatohepatitis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-alcoholic Steatohepatitis Revenue in 2024

3.5 Global Key Players of Non-alcoholic Steatohepatitis Head office and Area Served

3.6 Global Key Players of Non-alcoholic Steatohepatitis, Product and Application

3.7 Global Key Players of Non-alcoholic Steatohepatitis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-alcoholic Steatohepatitis Breakdown Data by Type

4.1 Global Non-alcoholic Steatohepatitis Historic Market Size by Type (2020-2025)

4.2 Global Non-alcoholic Steatohepatitis Forecasted Market Size by Type (2026-2031)

5 Non-alcoholic Steatohepatitis Breakdown Data by Application

5.1 Global Non-alcoholic Steatohepatitis Historic Market Size by Application (2020-2025)

5.2 Global Non-alcoholic Steatohepatitis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-alcoholic Steatohepatitis Market Size (2020-2031)

6.2 North America Non-alcoholic Steatohepatitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-alcoholic Steatohepatitis Market Size by Country (2020-2025)

6.4 North America Non-alcoholic Steatohepatitis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-alcoholic Steatohepatitis Market Size (2020-2031)

7.2 Europe Non-alcoholic Steatohepatitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-alcoholic Steatohepatitis Market Size by Country (2020-2025)

7.4 Europe Non-alcoholic Steatohepatitis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-alcoholic Steatohepatitis Market Size (2020-2031)

8.2 Asia-Pacific Non-alcoholic Steatohepatitis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-alcoholic Steatohepatitis Market Size (2020-2031)

9.2 Latin America Non-alcoholic Steatohepatitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-alcoholic Steatohepatitis Market Size by Country (2020-2025)

9.4 Latin America Non-alcoholic Steatohepatitis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-alcoholic Steatohepatitis Market Size (2020-2031)

10.2 Middle East & Africa Non-alcoholic Steatohepatitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Non-alcoholic Steatohepatitis Introduction

11.1.4 AstraZeneca Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.1.5 AstraZeneca Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Non-alcoholic Steatohepatitis Introduction

11.2.4 Pfizer Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 GSK

11.3.1 GSK Company Details

11.3.2 GSK Business Overview

11.3.3 GSK Non-alcoholic Steatohepatitis Introduction

11.3.4 GSK Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.3.5 GSK Recent Development

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Details

11.4.2 Novo Nordisk Business Overview

11.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Introduction

11.4.4 Novo Nordisk Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.4.5 Novo Nordisk Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Non-alcoholic Steatohepatitis Introduction

11.5.4 Roche Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.5.5 Roche Recent Development

11.6 AbbVie

11.6.1 AbbVie Company Details

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Non-alcoholic Steatohepatitis Introduction

11.6.4 AbbVie Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.6.5 AbbVie Recent Development

11.7 Galectin Therapeutics

11.7.1 Galectin Therapeutics Company Details

11.7.2 Galectin Therapeutics Business Overview

11.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Introduction

11.7.4 Galectin Therapeutics Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.7.5 Galectin Therapeutics Recent Development

11.8 Galmed Pharmaceuticals

11.8.1 Galmed Pharmaceuticals Company Details

11.8.2 Galmed Pharmaceuticals Business Overview

11.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Introduction

11.8.4 Galmed Pharmaceuticals Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.8.5 Galmed Pharmaceuticals Recent Development

11.9 Gilead

11.9.1 Gilead Company Details

11.9.2 Gilead Business Overview

11.9.3 Gilead Non-alcoholic Steatohepatitis Introduction

11.9.4 Gilead Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.9.5 Gilead Recent Development

11.10 Intercept pharma

11.10.1 Intercept pharma Company Details

11.10.2 Intercept pharma Business Overview

11.10.3 Intercept pharma Non-alcoholic Steatohepatitis Introduction

11.10.4 Intercept pharma Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.10.5 Intercept pharma Recent Development

11.11 Non-alcoholic Steatohepatitis

11.11.1 Non-alcoholic Steatohepatitis Company Details

11.11.2 Non-alcoholic Steatohepatitis Business Overview

11.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Introduction

11.11.4 Non-alcoholic Steatohepatitis Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.11.5 Non-alcoholic Steatohepatitis Recent Development

11.12 Takeda

11.12.1 Takeda Company Details

11.12.2 Takeda Business Overview

11.12.3 Takeda Non-alcoholic Steatohepatitis Introduction

11.12.4 Takeda Revenue in Non-alcoholic Steatohepatitis Business (2020-2025)

11.12.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

GSK

Novo Nordisk

Roche

Galectin Therapeutics

Galmed Pharmaceuticals

Gilead

Takeda

Pfizer Inc

AbbVie

Intercept pharma

Non-alcoholic Steatohepatitis

List of Tables

Table 1. Global Non-alcoholic Steatohepatitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Solid

Table 3. Key Players of Liquid

Table 4. Global Non-alcoholic Steatohepatitis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Non-alcoholic Steatohepatitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Non-alcoholic Steatohepatitis Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Non-alcoholic Steatohepatitis Market Share by Region (2020-2025)

Table 8. Global Non-alcoholic Steatohepatitis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Non-alcoholic Steatohepatitis Market Share by Region (2026-2031)

Table 10. Non-alcoholic Steatohepatitis Market Trends

Table 11. Non-alcoholic Steatohepatitis Market Drivers

Table 12. Non-alcoholic Steatohepatitis Market Challenges

Table 13. Non-alcoholic Steatohepatitis Market Restraints

Table 14. Global Non-alcoholic Steatohepatitis Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Non-alcoholic Steatohepatitis Market Share by Players (2020-2025)

Table 16. Global Top Non-alcoholic Steatohepatitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis as of 2024)

Table 17. Ranking of Global Top Non-alcoholic Steatohepatitis Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Non-alcoholic Steatohepatitis Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Non-alcoholic Steatohepatitis, Headquarters and Area Served

Table 20. Global Key Players of Non-alcoholic Steatohepatitis, Product and Application

Table 21. Global Key Players of Non-alcoholic Steatohepatitis, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-alcoholic Steatohepatitis Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Non-alcoholic Steatohepatitis Revenue Market Share by Type (2020-2025)

Table 25. Global Non-alcoholic Steatohepatitis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Non-alcoholic Steatohepatitis Revenue Market Share by Type (2026-2031)

Table 27. Global Non-alcoholic Steatohepatitis Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Non-alcoholic Steatohepatitis Revenue Market Share by Application (2020-2025)

Table 29. Global Non-alcoholic Steatohepatitis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Non-alcoholic Steatohepatitis Revenue Market Share by Application (2026-2031)

Table 31. North America Non-alcoholic Steatohepatitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Non-alcoholic Steatohepatitis Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Non-alcoholic Steatohepatitis Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Non-alcoholic Steatohepatitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Non-alcoholic Steatohepatitis Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Non-alcoholic Steatohepatitis Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Non-alcoholic Steatohepatitis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Non-alcoholic Steatohepatitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Non-alcoholic Steatohepatitis Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Non-alcoholic Steatohepatitis Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Non-alcoholic Steatohepatitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country (2026-2031) & (US$ Million)

Table 46. AstraZeneca Company Details

Table 47. AstraZeneca Business Overview

Table 48. AstraZeneca Non-alcoholic Steatohepatitis Product

Table 49. AstraZeneca Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 50. AstraZeneca Recent Development

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Non-alcoholic Steatohepatitis Product

Table 54. Pfizer Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. GSK Company Details

Table 57. GSK Business Overview

Table 58. GSK Non-alcoholic Steatohepatitis Product

Table 59. GSK Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 60. GSK Recent Development

Table 61. Novo Nordisk Company Details

Table 62. Novo Nordisk Business Overview

Table 63. Novo Nordisk Non-alcoholic Steatohepatitis Product

Table 64. Novo Nordisk Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 65. Novo Nordisk Recent Development

Table 66. Roche Company Details

Table 67. Roche Business Overview

Table 68. Roche Non-alcoholic Steatohepatitis Product

Table 69. Roche Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 70. Roche Recent Development

Table 71. AbbVie Company Details

Table 72. AbbVie Business Overview

Table 73. AbbVie Non-alcoholic Steatohepatitis Product

Table 74. AbbVie Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 75. AbbVie Recent Development

Table 76. Galectin Therapeutics Company Details

Table 77. Galectin Therapeutics Business Overview

Table 78. Galectin Therapeutics Non-alcoholic Steatohepatitis Product

Table 79. Galectin Therapeutics Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 80. Galectin Therapeutics Recent Development

Table 81. Galmed Pharmaceuticals Company Details

Table 82. Galmed Pharmaceuticals Business Overview

Table 83. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product

Table 84. Galmed Pharmaceuticals Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 85. Galmed Pharmaceuticals Recent Development

Table 86. Gilead Company Details

Table 87. Gilead Business Overview

Table 88. Gilead Non-alcoholic Steatohepatitis Product

Table 89. Gilead Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 90. Gilead Recent Development

Table 91. Intercept pharma Company Details

Table 92. Intercept pharma Business Overview

Table 93. Intercept pharma Non-alcoholic Steatohepatitis Product

Table 94. Intercept pharma Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 95. Intercept pharma Recent Development

Table 96. Non-alcoholic Steatohepatitis Company Details

Table 97. Non-alcoholic Steatohepatitis Business Overview

Table 98. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product

Table 99. Non-alcoholic Steatohepatitis Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 100. Non-alcoholic Steatohepatitis Recent Development

Table 101. Takeda Company Details

Table 102. Takeda Business Overview

Table 103. Takeda Non-alcoholic Steatohepatitis Product

Table 104. Takeda Revenue in Non-alcoholic Steatohepatitis Business (2020-2025) & (US$ Million)

Table 105. Takeda Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Non-alcoholic Steatohepatitis Picture

Figure 2. Global Non-alcoholic Steatohepatitis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-alcoholic Steatohepatitis Market Share by Type: 2024 VS 2031

Figure 4. Solid Features

Figure 5. Liquid Features

Figure 6. Global Non-alcoholic Steatohepatitis Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Non-alcoholic Steatohepatitis Market Share by Application: 2024 VS 2031

Figure 8. Oral Case Studies

Figure 9. Parenteral Case Studies

Figure 10. Non-alcoholic Steatohepatitis Report Years Considered

Figure 11. Global Non-alcoholic Steatohepatitis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Non-alcoholic Steatohepatitis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Non-alcoholic Steatohepatitis Market Share by Region: 2024 VS 2031

Figure 14. Global Non-alcoholic Steatohepatitis Market Share by Players in 2024

Figure 15. Global Top Non-alcoholic Steatohepatitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Non-alcoholic Steatohepatitis Revenue in 2024

Figure 17. North America Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Non-alcoholic Steatohepatitis Market Share by Country (2020-2031)

Figure 19. United States Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Non-alcoholic Steatohepatitis Market Share by Country (2020-2031)

Figure 23. Germany Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Non-alcoholic Steatohepatitis Market Share by Region (2020-2031)

Figure 31. China Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Non-alcoholic Steatohepatitis Market Share by Country (2020-2031)

Figure 39. Mexico Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Non-alcoholic Steatohepatitis Market Share by Country (2020-2031)

Figure 43. Turkey Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Non-alcoholic Steatohepatitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. AstraZeneca Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 47. Pfizer Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 48. GSK Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 49. Novo Nordisk Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 51. AbbVie Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 52. Galectin Therapeutics Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 53. Galmed Pharmaceuticals Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 54. Gilead Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 55. Intercept pharma Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 56. Non-alcoholic Steatohepatitis Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 57. Takeda Revenue Growth Rate in Non-alcoholic Steatohepatitis Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Alcoholic Steatohepatitis NASH Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis NASH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global NASH Non alcoholic Steatohepatitis Biomarkers Market Research Report 2024

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025

Global Non Alcoholic Fatty Liver Disease Treatment Market Research Report 2024

Global Non Alcoholic Steatohepatitis NASH Treatment Market Insights Forecast to 2030

Global Non alcoholic Steatohepatitis NASH Biomarkers Market Research Report 2024

Nonalcoholic Steatohepatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Alcoholic Steatohepatitis Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fatty Liver Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030

Global Liver Cirrhosis Market Research Report 2024

Global Compensated Cirrhosis Type C Market Research Report 2024

Alcoholic Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiac Cirrhosis Treatment Market Research Report 2024

Global Non Invasive Liver Monitor Market Research Report 2024

Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Fibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions